Heart Failure – New Guidelines, New Treatments
Learn more about the latest treatments for heart failure in this CPD-accredited report by a leading South African expert.
You will learn:
• Important aspects of the management of heart failure with reduced ejection fraction (HFrEF)
• The latest clinical evidence on the use of angiotensin receptor-neprilysin inhibitors, sodium-glucose co-transporter-2 inhibitors, and newer agents not yet available in South Africa for the treatment of HFrEF
• Heart failure guideline recommendations for the management of HFrEF using drug therapies and ancillary interventions.
WEBINAR HELD ON 6 OCTOBER 2021
ATTENTIONKindly note that if you attended the live webinar, you have already received 1 CPD point and will not be permitted to receive additional points for the report. Should this occur, the HPCSA will only record the 1 CPD point from the live webinar, invalidating any additional CPD points from the report.
Please note deNovo Medica ensures uploading of your CPD points to the HPCSA: please don’t upload these yourself.
To access this module, please register or login:
Case study with Dr Mpe
